ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,643Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 387

$896K Total Retail Price of All Prescriptions

Rank: 41 out of 387

599 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 14,865 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
SIMVASTATIN 776 705 1 5
OMEPRAZOLE 635 542 2 4
HYDROCODONE-ACETAMINOPHEN 539 403 S3 3 1
LEVOTHYROXINE SODIUM 356 334 4 2
POTASSIUM CHLORIDE 349 318 5 9
HYDROCHLOROTHIAZIDE 336 313 6 12
LISINOPRIL 325 301 7 3
METFORMIN HCL ER 323 309 8 81
METOPROLOL TARTRATE 317 297 9 11
GABAPENTIN 292 242 10 10
TRAMADOL HCL 289 262 11 14
AMLODIPINE BESYLATE 286 267 12 6
FUROSEMIDE 278 255 13 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 250 211 14 30
ATORVASTATIN CALCIUM 245 242 15 13
SERTRALINE HCL 237 198 16 23
MELOXICAM 234 208 17 22
PRAVASTATIN SODIUM 201 175 18 15
TAMSULOSIN HCL 189 157 19 32
LOSARTAN POTASSIUM 180 179 20 24
ATENOLOL 177 165 21 20
ALLOPURINOL 176 170 22 28
LOSARTAN-HYDROCHLOROTHIAZIDE 173 161 23 65
DILTIAZEM 24HR CD 156 156 24 118
GLIMEPIRIDE 147 143 25 50
ISOSORBIDE MONONITRATE ER 143 141 26 59
DIGOXIN 143 143 26 40
CRESTOR 133 125 28 34
NAMENDA 132 132 29 35
GLYBURIDE 128 125 R 30 58
ALENDRONATE SODIUM 127 121 31 31
NEXIUM 126 118 32 26
WARFARIN SODIUM 125 125 33 17
CLOPIDOGREL 124 114 34 25
DONEPEZIL HCL 122 122 35 27
CLONIDINE HCL 120 111 36 38
CARVEDILOL 117 117 37 21
METFORMIN HCL 116 91 38 8
CITALOPRAM HBR 113 86 39 19
VERAPAMIL ER 113 109 39 87
INDAPAMIDE 112 109 41 215
DOXAZOSIN MESYLATE 108 108 42 75
FLUTICASONE PROPIONATE 104 86 43 29
ADVAIR DISKUS 101 83 44 41
ZETIA 95 93 45 96
LOVASTATIN 95 95 45 36
FLUOXETINE HCL 91 71 47 46
VENLAFAXINE HCL ER 89 60 48 97
KLOR-CON M20 89 89 48 76
RANITIDINE HCL 88 86 50 45
PLAVIX 87 82 51 39
DICLOFENAC SODIUM 85 74 52 115
GEMFIBROZIL 83 76 53 93
ZOLPIDEM TARTRATE 83 74 53 16
MORPHINE SULFATE ER 81 65 S2 55 79
LEVOFLOXACIN 81 64 55 84
METOPROLOL SUCCINATE 80 80 57 18
LANTUS 77 56 58 51
PROAIR HFA 75 61 59 47
ETODOLAC 74 56 60 183
CYCLOBENZAPRINE HCL 73 52 R 61 42
SYNTHROID 73 61 61 68
ROPINIROLE HCL 72 72 63 91
AZITHROMYCIN 72 67 63 49
TIZANIDINE HCL 72 67 63 127
CARBIDOPA-LEVODOPA 71 71 66 104
BENAZEPRIL HCL 71 68 66 86
RISPERIDONE 71 49 66 70
JANUVIA 70 70 69 60
LYRICA 69 69 70 66
FENOFIBRATE 66 64 71 106
PANTOPRAZOLE SODIUM 63 55 72 48
FELODIPINE ER 62 51 73 130
PEN NEEDLE 60 54 74 173
POLYETHYLENE GLYCOL 3350 59 59 75 57
FINASTERIDE 59 55 75 95
IBUPROFEN 57 47 77 85
DIOVAN HCT 57 57 77 74
TRAZODONE HCL 55 29 79 37
INSULIN SYRINGE 54 41 80 151
OXYCONTIN 53 20 S2 81 92
CARISOPRODOL 53 20 R 81 53
SPIRONOLACTONE 52 52 83 67
ACETAMINOPHEN-CODEINE 51 39 S3 84 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.